Pulmonx annual total assets
2019
2020
2021
2022
2023
2024
2025
Pulmonx Total Assets Growth & History (LUNG)
Pulmonx's total assets was $129.3M for fiscal 2025.
View full Pulmonx company overviewPulmonx annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $129.3M | −$33.6M | −20.61% |
| 2024 | 2024-12-31 | $162.8M | −$14.9M | −8.40% |
| 2023 | 2023-12-31 | $177.8M | −$15.9M | −8.21% |
| 2022 | 2022-12-31 | $193.7M | −$41.5M | −17.65% |
| 2021 | 2021-12-31 | $235.2M | −$28.5M | −10.82% |
| 2020 | 2020-12-31 | $263.7M | $210.2M | +392.61% |
| 2019 | 2019-12-31 | $53.5M | — | — |
Pulmonx quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $114.7M | −$32.5M | −22.05% |
| Q1 2026 | 2026-03-31 | $120.0M | −$30.8M | −20.41% |
| Q4 2025 | 2025-12-31 | $129.3M | −$33.6M | −20.61% |
| Q3 2025 | 2025-09-30 | $138.3M | −$29.1M | −17.40% |
| Q2 2025 | 2025-06-30 | $147.2M | −$25.4M | −14.74% |
| Q1 2025 | 2025-03-31 | $150.7M | −$13.8M | −8.41% |
| Q4 2024 | 2024-12-31 | $162.8M | −$14.9M | −8.40% |
| Q3 2024 | 2024-09-30 | $167.4M | −$17.6M | −9.52% |
| Q2 2024 | 2024-06-30 | $172.6M | −$20.5M | −10.61% |
| Q1 2024 | 2024-03-31 | $164.6M | −$36.7M | −18.23% |
| Q4 2023 | 2023-12-31 | $177.8M | −$15.9M | −8.21% |
| Q3 2023 | 2023-09-30 | $185.0M | −$17.2M | −8.50% |
| Q2 2023 | 2023-06-30 | $193.1M | −$19.6M | −9.22% |
| Q1 2023 | 2023-03-31 | $201.3M | −$21.6M | −9.68% |
| Q4 2022 | 2022-12-31 | $193.7M | −$41.5M | −17.65% |
| Q3 2022 | 2022-09-30 | $202.2M | −$44.6M | −18.08% |
| Q2 2022 | 2022-06-30 | $212.7M | −$36.2M | −14.55% |
| Q1 2022 | 2022-03-31 | $222.8M | −$32.4M | −12.70% |
| Q4 2021 | 2021-12-31 | $235.2M | −$28.5M | −10.82% |
| Q3 2021 | 2021-09-30 | $246.8M | $175.6M | +246.44% |
| Q2 2021 | 2021-06-30 | $248.9M | — | — |
| Q1 2021 | 2021-03-31 | $255.3M | — | — |
| Q4 2020 | 2020-12-31 | $263.7M | $210.2M | +392.61% |
| Q3 2020 | 2020-09-30 | $71.2M | — | — |
| Q4 2019 | 2019-12-31 | $53.5M | — | — |
Pulmonx total assets trends
Over the last five fiscal years, Pulmonx's total assets decreased from $263.7M to $129.3M, a change of −$134.4M. The latest reported quarter, Q2 2026, shows $114.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pulmonx source filings ↗